AnalystsLaura PrendergastLaura Prendergast's Stock Forecasts
AnalystsLaura Prendergast
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4244 out of 4870 analysts
Average Return
-32.31%
Win Rate
25%2 out of 8
Risk vs Reward
Poor
Good
Laura Prendergast Analyst Color
Get additional color on Laura Prendergast's coverage of popular stocks
Laura Prendergast's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Erasca IncERAS | 1 | Buy | $5.00 | +235.57% | Initiates Coverage On | a month ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $18.00 | +589.66% | Initiates Coverage On | 7 months ago |
Nkarta IncNKTX | 2 | Strong Buy | $16.00 | +680.49% | Upgrades | 9 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $20.00 | +1,076.47% | Initiates Coverage On | 9 months ago |
Third Harmonic Bio IncTHRD | 1 | Buy | $18.00 | +248.84% | Initiates Coverage On | a year ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $48.00 | N/A | Upgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.